Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Reexamination Certificate
2006-06-13
2006-06-13
Tsang, Cecilia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
C562S506000
Reexamination Certificate
active
07060728
ABSTRACT:
11,12-Oxidoarachidonic acid derivatives and methods of their use for treating dry eye are disclosed.
REFERENCES:
patent: 3991759 (1976-11-01), Urquhart
patent: 4131651 (1978-12-01), Shah et al.
patent: 4370325 (1983-01-01), Packman
patent: 4409205 (1983-10-01), Shively
patent: 4744980 (1988-05-01), Holly
patent: 4804539 (1989-02-01), Guo et al.
patent: 4818537 (1989-04-01), Guo
patent: 4883658 (1989-11-01), Holly
patent: 4914088 (1990-04-01), Glonek et al.
patent: 4966773 (1990-10-01), Gressel et al.
patent: 5041434 (1991-08-01), Lubkin
patent: 5075104 (1991-12-01), Gressel et al.
patent: 5174988 (1992-12-01), Mautone et al.
patent: 5278151 (1994-01-01), Korb et al.
patent: 5290572 (1994-03-01), MacKeen
patent: 5294607 (1994-03-01), Glonek et al.
patent: 5371108 (1994-12-01), Korb et al.
patent: 5403841 (1995-04-01), Lang et al.
patent: 5578586 (1996-11-01), Glonek et al.
patent: 5696166 (1997-12-01), Yanni et al.
patent: 5800807 (1998-09-01), Hu et al.
patent: 6153607 (2000-11-01), Pflugfelder et al.
patent: WO 00/18706 (2000-04-01), None
Nicolaou et al., J. Am. Chem. Soc., 2001, 123, 9313-9323.
Charette et al., Angew. Chem. Int. Ed. Engl., 1997, 36, 1090-1092.
Gao et al., “Total Synthesis of (-)-Dactylynes,” Heterocycles, vol. 42(2), pp. 745-774 (1996).
Han et al.,-“A Short Catalytic Enantioselective Synthesis of the Vascular Antiinflammatory Eicosanoid (11R,12S)-Oxidoarachidonic Acid,”Organic Letters, vol. 2(22), pp. 3437-3438 (2000).
Katritzky et al., “Stereoselective Syntheses of β,γ-Unsaturated Esters and γ-Lactones: 1-(Benzotriazol-1-yl)-3-(diphenylphosphoryl)-1-ethoxy-1-propene, a Protected= CCH2CO2Et Synthon Equivalent,”J. Org. Chem., vol. 62, pp. 4131-4136 (1997).
Lemp et al., “Report of the National Eye Institute/Industry Workshop on Clinical Trials in Dry Eyes,”The CLAO Journal, vol. 21(4), pp. 221-231 (1995).
Marsh et al., “Topical Nonpreserved Methylprednisolone Therapy for Keratoconjunctivitis Sicca in Sjögren Syndrome,”Ophthalmology, vol. 106(4), pp. 811-816 (1999).
McCulley et al., “Tear Film Structure and Dry Eye,”Contactologia, vol. 20, pp. 145-149 (1998).
Ohno, M.; Otsuka, M. Organic Reactions, vol. 37, Chapter 1 (1989).
Sharpless et al., “The Osmium-Catalyzed Asymmetric Dihydroxylation: A New Ligand Class and a Process Improvement,”J. Org. Chem., vol. 57, pp. 2768-2771 (1992).
Shine et al., Keratoconjunctivitis Sicca Associated with Meibomian Secretion Polar Lipid Abnormality,Arch. Ophthalmology, vol. 116, pp. 849-852 (1998).
Zamboni et al., “The Stereospecific Synthesis of 14S, 15S-Oxido 5Z, 8Z, 10E, 12E-Eicosatetraenoic Acid,”Tetrahedron Letters, vol. 24(45), pp. 4899-4902 (1983).
Belanger David B.
Klimko Peter G.
Alcon Inc.
Perlinger Sarah
Ryan Patrick M.
Tsang Cecilia
LandOfFree
11,12-oxidoarachidonic acid derivatives and methods of their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 11,12-oxidoarachidonic acid derivatives and methods of their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 11,12-oxidoarachidonic acid derivatives and methods of their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3692718